These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

496 related articles for article (PubMed ID: 33499003)

  • 1. Radiation and Immunotherapy in Upper Gastrointestinal Cancers: The Current State of Play.
    Donlon NE; Power R; Hayes C; Davern M; Reynolds JV; Lysaght J
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33499003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiotherapy, immunotherapy, and the tumour microenvironment: Turning an immunosuppressive milieu into a therapeutic opportunity.
    Donlon NE; Power R; Hayes C; Reynolds JV; Lysaght J
    Cancer Lett; 2021 Apr; 502():84-96. PubMed ID: 33450360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combinational Immunotherapy for Hepatocellular Carcinoma: Radiotherapy, Immune Checkpoint Blockade and Beyond.
    Lee YH; Tai D; Yip C; Choo SP; Chew V
    Front Immunol; 2020; 11():568759. PubMed ID: 33117354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination immunotherapy strategies for glioblastoma.
    Chan HY; Choi J; Jackson C; Lim M
    J Neurooncol; 2021 Feb; 151(3):375-391. PubMed ID: 33611705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the immune milieu in gastrointestinal cancers.
    Turkes F; Mencel J; Starling N
    J Gastroenterol; 2020 Oct; 55(10):909-926. PubMed ID: 32748171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting the tumour immune microenvironment for cancer therapy in human gastrointestinal malignancies.
    Zhang Y; Xu J; Zhang N; Chen M; Wang H; Zhu D
    Cancer Lett; 2019 Aug; 458():123-135. PubMed ID: 31121212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting Metabolism to Improve the Tumor Microenvironment for Cancer Immunotherapy.
    Bader JE; Voss K; Rathmell JC
    Mol Cell; 2020 Jun; 78(6):1019-1033. PubMed ID: 32559423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel Use of Low-Dose Radiotherapy to Modulate the Tumor Microenvironment of Liver Metastases.
    He K; Barsoumian HB; Bertolet G; Verma V; Leuschner C; Koay EJ; Ludmir EB; Hsu E; Pisipati E; Voss TA; Puebla-Osorio N; Cortez MA; Welsh JW
    Front Immunol; 2021; 12():812210. PubMed ID: 34975924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncolytic Newcastle disease virus expressing a checkpoint inhibitor as a radioenhancing agent for murine melanoma.
    Vijayakumar G; Palese P; Goff PH
    EBioMedicine; 2019 Nov; 49():96-105. PubMed ID: 31676387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapy and radiation combinatorial trials in gynecologic cancer: A potential synergy?
    Lee L; Matulonis U
    Gynecol Oncol; 2019 Jul; 154(1):236-245. PubMed ID: 30995960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoadjuvant immunotherapy in gastrointestinal cancers - The new standard of care?
    Petricevic B; Kabiljo J; Zirnbauer R; Walczak H; Laengle J; Bergmann M
    Semin Cancer Biol; 2022 Nov; 86(Pt 2):834-850. PubMed ID: 35671877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiotherapy and immunotherapy: a beneficial liaison?
    Weichselbaum RR; Liang H; Deng L; Fu YX
    Nat Rev Clin Oncol; 2017 Jun; 14(6):365-379. PubMed ID: 28094262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The complementarity of DDR, nucleic acids and anti-tumour immunity.
    Kornepati AVR; Rogers CM; Sung P; Curiel TJ
    Nature; 2023 Jul; 619(7970):475-486. PubMed ID: 37468584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noninvasively Deciphering the Immunosuppressive Tumor Microenvironment Using Galectin-1 PET to Inform Immunotherapy Responses.
    Liu N; Yang X; Gao C; Wang J; Zeng Y; Zhang L; Yin Q; Zhang T; Zhou H; Li K; Du J; Zhou S; Zhao X; Zhu H; Yang Z; Liu Z
    J Nucl Med; 2024 May; 65(5):728-734. PubMed ID: 38514084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Tumor Microenvironment in the Response to Immune Checkpoint Blockade Therapies.
    Petitprez F; Meylan M; de Reyniès A; Sautès-Fridman C; Fridman WH
    Front Immunol; 2020; 11():784. PubMed ID: 32457745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combining immunotherapy and radiation therapy in gastrointestinal cancers: A review.
    Mitrea DA; Froicu EM; Prenen H; Gambacorta MA; Span PN; Poortmans P
    Crit Rev Oncol Hematol; 2024 Jul; 199():104381. PubMed ID: 38735504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune targets in the tumor microenvironment treated by radiotherapy.
    Ozpiskin OM; Zhang L; Li JJ
    Theranostics; 2019; 9(5):1215-1231. PubMed ID: 30867826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune effects of targeted radiation therapy for cancer.
    Sridharan V; Schoenfeld JD
    Discov Med; 2015 Mar; 19(104):219-28. PubMed ID: 25828526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotherapy and radiotherapy in melanoma: a multidisciplinary comprehensive review.
    Tagliaferri L; Lancellotta V; Fionda B; Mangoni M; Casà C; Di Stefani A; Pagliara MM; D'Aviero A; Schinzari G; Chiesa S; Mazzarella C; Manfrida S; Colloca GF; Marazzi F; Morganti AG; Blasi MA; Peris K; Tortora G; Valentini V
    Hum Vaccin Immunother; 2022 May; 18(3):1903827. PubMed ID: 33847208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotherapy-based combination strategies for treatment of gastrointestinal cancers: current status and future prospects.
    Zhou C; Zhang J
    Front Med; 2019 Feb; 13(1):12-23. PubMed ID: 30796606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.